Tags |
|
|
Links |
|
|
Advice You - Motivational Speaker Asks: Do You Want To Be A Close Second In A Race?
My Chicago White Sox are a mysterious team in 2006.
In 2005, as you know, they became Wor
In 2005, as you know, they became Wor
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ld Series Champions, for the first time in about 80 years.
Having vanquished their thirst
Having vanquished their thirst
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
for victory, they got off to a bumbling start this year, and then they let the Detroit Ti
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
gers sneak into first place, a slot they’ve been occupying for two or more weeks.
The Sox
The Sox
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
are trailing by a game and a half, and I’m wondering if that’s exactly where they want to
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
be for the next month or two.
Why would they choose to be a close second?
(1) They migh
Why would they choose to be a close second?
(1) They migh
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
t believe that the pressure is on the new leaders. After all, the Tigers haven’t earned th
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
eir stripes in a post-season in a long, long time, so they’re not used to the heat of cont
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
ention.
(2) The Sox might be welcoming a small cessation in press scrutiny. Talk about he
(2) The Sox might be welcoming a small cessation in press scrutiny. Talk about he
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
at, the kitchen was warming up quite a bit when they were struggling, and being a solid se
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
ond gets them some press, but the real heat is always on the leader.
(3) It’s like a foot
(3) It’s like a foot
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
race. When you’re a close second, you can pace the leader, seeing his every step and wait
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ing for the misstep before bolting forward. He’s always wondering when you’re going to tur
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
n on the afterburners, feeling your eyes burning through his back.
(4) It makes them humb
(4) It makes them humb
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
le. Uncontested champs get lazy, look lackadaisical, and garner disrespect. Being in secon
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
d, they seem like the old Avis ad: “We try harder.”
(5) At this rate of winning, the Sox
(5) At this rate of winning, the Sox
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
will still make it to the post-season as the Wild Card Champs. They may be behind the Tige
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
rs by one and a half, but they’re number one in the Wild Card race.
Losing isn’t fun, and
Losing isn’t fun, and
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
the best view is always reserved for the lead dog.
Still, there’s something to be said f
Still, there’s something to be said f
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
or being a close second, whether it’s in baseball, or possibly in any competitive endeavor
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/39691/adviceyou-Motivational-Speaker-Asks-Do-You-Want-To-Be-A-Close-Second-In-A-Race.html">Motivational Speaker Asks: Do You Want To Be A Close Second In A Race?</a>
BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/39691/adviceyou-Motivational-Speaker-Asks-Do-You-Want-To-Be-A-Close-Second-In-A-Race.html]Motivational Speaker Asks: Do You Want To Be A Close Second In A Race?[/url]
Related Articles:
Redundancy - Contradictory New Rulings On Ageism May Lead to Unfair Dismissal
The Benefits of a Strong Sales Letter
Bookmark it:
|